ADMA Biologics (ADMA) Reports Q2 Loss of $0.35/Share

ADMA Biologics (NASDAQ: ADMA) reported Q2 EPS of ($0.35), versus ($0.55) reported last year. Revenue for the quarter came in at $4.7 million, versus $3.4 million reported last year.

For earnings history and earnings-related data on ADMA Biologics (ADMA) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat